GAVE
MCID: GST020
MIFTS: 42

Gastric Antral Vascular Ectasia (GAVE)

Categories: Blood diseases, Cardiovascular diseases, Gastrointestinal diseases, Rare diseases

Aliases & Classifications for Gastric Antral Vascular Ectasia

MalaCards integrated aliases for Gastric Antral Vascular Ectasia:

Name: Gastric Antral Vascular Ectasia 12 53 44 15 17
Watermelon Stomach 12 75 53
Gave 53

Classifications:



External Ids:

Disease Ontology 12 DOID:2493
MeSH 44 D020252
NCIt 50 C84724
SNOMED-CT 68 43935004
UMLS 72 C0267211

Summaries for Gastric Antral Vascular Ectasia

NIH Rare Diseases : 53 Watermelon stomach is a condition in which the lining of the stomach bleeds, causing it to look like the characteristic stripes of a watermelon when viewed by endoscopy. Although it can develop in men and women of all ages, watermelon stomach is most commonly observed in older women (over age 70 years). Signs and symptoms of watermelon stomach include blood in the stool, hematemesis (vomiting blood) and anemia. The exact cause of watermelon stomach is unknown; however, it is often diagnosed in people with other chronic (long-term) conditions such as cirrhosis (scarring of the liver and poor liver function), autoimmune disease, systemic sclerosis, and CREST syndrome. Treatment consists of surgery and/or medications to stop or control the bleeding.

MalaCards based summary : Gastric Antral Vascular Ectasia, also known as watermelon stomach, is related to active peptic ulcer disease and portal hypertension. An important gene associated with Gastric Antral Vascular Ectasia is ANGPTL4 (Angiopoietin Like 4). The drugs Acetylcholine and Peginterferon alfa-2a have been mentioned in the context of this disorder. Affiliated tissues include liver, testes and heart, and related phenotypes are digestive/alimentary and immune system

Wikipedia : 75 Gastric antral vascular ectasia (GAVE) is an uncommon cause of chronic gastrointestinal bleeding or iron... more...

Related Diseases for Gastric Antral Vascular Ectasia

Diseases related to Gastric Antral Vascular Ectasia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 235)
# Related Disease Score Top Affiliating Genes
1 active peptic ulcer disease 30.7 ATP4A ATP12A
2 portal hypertension 30.5 SST CTC1
3 esophageal varix 29.8 SST ATP4A ATP12A
4 stomach disease 29.1 SST ATP4A ATP12A
5 transcobalamin ii deficiency 11.3
6 campomelic dysplasia 11.1
7 hyperlipidemia, familial combined, 3 11.1
8 marfan syndrome 11.1
9 pseudo-von willebrand disease 11.1
10 spherocytosis, type 1 11.1
11 progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 1 11.1
12 smith-lemli-opitz syndrome 11.1
13 ichthyosis, x-linked 11.1
14 sacral defect with anterior meningocele 11.1
15 agammaglobulinemia 1, autosomal recessive 11.1
16 ehlers-danlos syndrome 11.1
17 iron metabolism disease 11.0
18 deficiency anemia 10.9
19 iron deficiency anemia 10.9
20 scleroderma, familial progressive 10.9
21 liver cirrhosis 10.8
22 gastritis 10.6
23 systemic scleroderma 10.6
24 autoimmune disease 10.6
25 varicose veins 10.6
26 primary biliary cirrhosis 10.5
27 primary biliary cholangitis 10.5
28 liver disease 10.4
29 connective tissue disease 10.4
30 end stage renal failure 10.4
31 hematopoietic stem cell transplantation 10.4
32 angiodysplasia 10.4
33 atrophic gastritis 10.4
34 pernicious anemia 10.3
35 sjogren syndrome 10.3
36 gastrointestinal stromal tumor 10.3
37 leukemia, chronic myeloid 10.3
38 telangiectasis 10.3
39 alcoholic liver cirrhosis 10.3
40 vascular disease 10.3
41 proctitis 10.3
42 kidney disease 10.3
43 chronic kidney disease 10.3
44 radiation proctitis 10.3
45 systemic lupus erythematosus 10.2
46 crest syndrome 10.2
47 lupus erythematosus 10.2
48 infertility 10.2
49 alzheimer disease 10.1
50 resting heart rate, variation in 10.1

Graphical network of the top 20 diseases related to Gastric Antral Vascular Ectasia:



Diseases related to Gastric Antral Vascular Ectasia

Symptoms & Phenotypes for Gastric Antral Vascular Ectasia

MGI Mouse Phenotypes related to Gastric Antral Vascular Ectasia:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 9.26 ANGPTL4 ATP12A ATP4A SST
2 immune system MP:0005387 9.02 ANGPTL4 ATP4A CTC1 GIT2 SST

Drugs & Therapeutics for Gastric Antral Vascular Ectasia

Drugs for Gastric Antral Vascular Ectasia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 676)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Acetylcholine Approved, Investigational Phase 4 51-84-3 187
2
Peginterferon alfa-2a Approved, Investigational Phase 4 198153-51-4 5360545
3
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
4
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
5
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
6
Metformin Approved Phase 4 657-24-9 4091 14219
7
Zinc Approved, Investigational Phase 4 7440-66-6 32051
8
Remifentanil Approved Phase 4 132875-61-7 60815
9
Misoprostol Approved Phase 4 59122-46-2 5282381
10
Ropivacaine Approved Phase 4 84057-95-4 71273 175805
11 Lycopene Approved, Investigational Phase 4 502-65-8 53477748
12
Dexmedetomidine Approved, Vet_approved Phase 4 113775-47-6 68602 5311068
13
Prednisone Approved, Vet_approved Phase 4 53-03-2 5865
14
Sargramostim Approved, Investigational Phase 4 83869-56-1, 123774-72-1
15
Lenograstim Approved, Investigational Phase 4 135968-09-1
16
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
17
Sevoflurane Approved, Vet_approved Phase 4 28523-86-6 5206
18
Sufentanil Approved, Investigational Phase 4 56030-54-7 41693
19
Iodine Approved, Investigational Phase 4 7553-56-2 807
20
Digoxin Approved Phase 4 20830-75-5 30322 2724385
21
Miconazole Approved, Investigational, Vet_approved Phase 4 22916-47-8 4189
22
Citalopram Approved Phase 4 59729-33-8 2771
23
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
24
Sertraline Approved Phase 4 79617-96-2 68617
25
Vortioxetine Approved, Investigational Phase 4 508233-74-7 9966051
26
Olmesartan Approved, Investigational Phase 4 144689-63-4, 144689-24-7 130881 158781
27
Valsartan Approved, Investigational Phase 4 137862-53-4 60846
28 sodium fluoride Approved Phase 4 7681-49-4
29
carbamide peroxide Approved Phase 4 124-43-6
30
Atorvastatin Approved Phase 4 134523-00-5 60823
31
Insulin glargine Approved Phase 4 160337-95-1
32
Repaglinide Approved, Investigational Phase 4 135062-02-1 65981
33
Dulaglutide Approved, Investigational Phase 4 923950-08-7
34
Insulin Aspart Approved Phase 4 116094-23-6 16132418
35
Quinapril Approved, Investigational Phase 4 85441-61-8 54892
36
Povidone-iodine Approved Phase 4 25655-41-8
37
Loperamide Approved Phase 4 53179-11-6 3955
38
Azithromycin Approved Phase 4 83905-01-5 447043 55185
39
Valproic acid Approved, Investigational Phase 4 99-66-1 3121
40
Sirolimus Approved, Investigational Phase 4 53123-88-9 6436030 5284616 46835353
41
Everolimus Approved Phase 4 159351-69-6 6442177 70789204
42
Ephedrine Approved Phase 4 299-42-3 9294
43
Pseudoephedrine Approved Phase 4 90-82-4 7028
44
Imipenem Approved Phase 4 74431-23-5, 64221-86-9 104838
45
Diclofenac Approved, Vet_approved Phase 4 15307-86-5 3033
46
Insulin Lispro Approved Phase 4 133107-64-9
47
Povidone Approved Phase 4 9003-39-8
48 Propoxycaine Approved Phase 4 86-43-1
49
Heparin Approved, Investigational Phase 4 9005-49-6 46507594 772
50
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244

Interventional clinical trials:

(show top 50) (show all 782)
# Name Status NCT ID Phase Drugs
1 The Use of Toxin Botulinum A Toxin in Patients With Parkinson's Disease and Multiple System Disease, Affected by Refractory Detrusor Overactivity. Unknown status NCT00822913 Phase 4 Intravesical injection of Botulinum A toxin
2 Bioequivalence Study of Tansulosine 0,4 mg Capsule in Health Subjects -Fed State Unknown status NCT01338623 Phase 4 Tansulosine
3 The Changes of CD8+T Cells Frequency and Function During Pegylated Interferon α-2a and Nucleoside Analogues Treatment in Patients With Chronic Hepatitis B Unknown status NCT03209037 Phase 4 Peginterferon Alfa-2a
4 The Changes of CD4+T Cells Frequency and Function During Pegylated Interferon α-2a and Nucleoside Analogues Treatment in Patients With Chronic Hepatitis B Unknown status NCT03209011 Phase 4 Peginterferon Alfa-2a
5 The Changes of Natural Killer Cells Frequency and Function During Pegylated Interferon α-2a and Nucleoside Analogues Treatment in Patients With Chronic Hepatitis B. Unknown status NCT03208998 Phase 4 Peginterferon Alfa-2a
6 The Effect of Intravenous Oxytocin Infusion Using Different Diluents on Neonatal Bilirubin & Sodium Levels .A Prospective Randomized Controlled Trial. Unknown status NCT02602301 Phase 4 Oxytocin
7 A Randomized Controlled Trial Comparing Combined Spinal- Epidural Dosing Strategies for External Cephalic Version Unknown status NCT01991743 Phase 4 Group 2.5;Group 5;Group 7.5;Group 10
8 Effect of Bispectral Index (BIS) Monitoring on Faster Recovery Time and Analgesic Consumption in Abdominal Surgery Patients Unknown status NCT01470898 Phase 4
9 Weight Reduction Alone May Not be Sufficient to Maintain Disease Remission in Obese Patients With Psoriasis: a Randomized, Investigator-blinded Study Unknown status NCT01439425 Phase 4
10 Evaluation Whether Higher Retention Rate is in Those of Combined Methadone With N-Acetyl-Cysteine Compared to Those With Methadone Alone During a Six-month Study Unknown status NCT01047956 Phase 4 Methadone; NAC;Methadone
11 A Comparison of the Effects of Ketamine and Remifentanil on Serum Cystatin-c Levels in CABG Surgery Completed NCT02113150 Phase 4 remifentanil;Ketamine
12 Delivery of Iron and Zinc Supplements: Evaluation of Interaction Effect on Biochemical and Clinical Outcomes Completed NCT00470158 Phase 4
13 Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood Completed NCT02839902 Phase 4 TAK-085
14 Effects of Vitamin D Supplements on Pregnancy Outcomes in Embriyo Transfer Cycles Completed NCT03890458 Phase 4 DEVIT-3
15 Pharmacokinetics of Metformin Intolerance Completed NCT03361878 Phase 4 Metformin Hydrochloride
16 Systemic Lycopene as an Adjunct to Scaling and Rootplaning in Chronic Periodontitis Patients With Type 2 Diabetes Mellitus Completed NCT02263352 Phase 4 Lycored soft gels Jagsonpal Pharma, Systemic 8mgms/day
17 Demonstrate the Lot-to-lot Consistency of 3 Consecutive Batches and to Evaluate the Efficacy and Safety of GC FLU®Pre-filled Syringe Injection and 'GC FLU®Injection' Administration. Completed NCT02067117 Phase 4 GC FLU® Injection, GC FLU® Pre-filled Syringe Injection
18 Effects of Dexmedetomidine on Stress Response and Postoperative Analgesia in Patients Undergoing Thoracotomy During Anesthesia Recovery Period Completed NCT01517932 Phase 4 dexmedetomidine;saline placebo
19 Long-term Follow-up at 10 Years of Patients Enrolled in the Fingolimod Phase II Program in Relapsing Multiple Sclerosis (MS) Completed NCT02307838 Phase 4
20 The Impact of Different Doses of Vitamin A Supplementation on Male and Female Childhood Morbidity and Mortality Completed NCT00168636 Phase 4 Vitamin A
21 A Randomized, Double-blind Clinical Trial of Two Inactivated Hepatitis A Vaccines in Healthy Children Completed NCT01252680 Phase 4
22 Blood Levels of Neurosteroids and Neurotrophic Factors in Normal Controls and in Patients With Major Depression Completed NCT00812994 Phase 4 Escitalopram;Placebo
23 Randomized, Cross-over Trial With Metformin in Women With Polycystic Ovary Syndrome Completed NCT02280057 Phase 4 Metformin;Placebo
24 Vortioxetine Versus Sertraline in Control Metabolic, Distress and Depression in Mexican Patients With Type 2 Diabetes Completed NCT03978286 Phase 4 Vortioxetine;Sertraline
25 Effectiveness of Nebulized Hypertonic Saline and Epinephrine in Hospitalized Infants With Bronchiolitis Completed NCT01300325 Phase 4
26 A Randomized, Double-blind, Active Control, 3-parallel Group, Forced Titration, Multicenter, Phase IV Study to Evaluate the Efficacy and Safety of Fimasartan Versus Valsartan Monotherapy in Patients With Mild to Moderate Essential Hypertension Completed NCT02495324 Phase 4 Placebo;Fimasartan;Valsartan;Olmesartan medoxomil
27 Transcranial Direct Current Stimulation for Treatment of Childhood Pharmacoresistant Lennox-Gastaut Syndrome, A Pilot Study Completed NCT02731300 Phase 4
28 Potential Biomarkers for Atherosclerosis in Type 2 Diabetic Patients Maintained on Statin Therapy Completed NCT03784703 Phase 4 Atorvastatin (Atrostat®, Delta Pharmaceutical Industries, Cairo, Egypt) tablets.;Rosuvastatin (Rosuvastatin Calcium®, Chemipharm Co.
29 Arterial Stiffness and Endothelial Function Indexes, Relationships With Clinical and Laboratory Variables in a Group of Diabetic Patients in Treatment With Dulaglutide: a Case-control Study Completed NCT03824002 Phase 4 Dulaglutide;Aspart insulin;Glargine;Metformin;Repaglinide
30 Comparison of Outcomes of Two Approaches in Microsurgical Varicocelectomy in Chinese Infertile Males: A Prospective Randomized, Controlled Trial Completed NCT01463787 Phase 4
31 The Ischemia Management With Accupril Post Bypass Graft Via Inhibition of the coNverting Enzyme (IMAGINE) Trial Completed NCT00269243 Phase 4 Quinapril
32 Comparison of Digoxin and Ivabradine in Heart Failure With Preserved Systolic Function. Time to Rethink About Digoxin. Completed NCT01699776 Phase 4 Ivabradine;Digoxin
33 Controlled Trial in Women With Recurrent Miscarriage of G-CSF Versus Placebo Completed NCT00772122 Phase 4 G-CSF;saline solution
34 Loperamide Plus Azithromycin More Effectively Treats Travelers' Diarrhea In Mexico Than Azithromycin Alone Completed NCT00359970 Phase 4 Azithromycin 500 mg;Azithromycin 1000 mg;Loperamide
35 Absorption of Orally Ingested Phosphate in Head and Neck Cancer Patients With and Without Refeeding Syndrome Completed NCT02880072 Phase 4
36 Safety, Acceptability and Efficacy of a Silica Dentifrice Containing Blue Pigment on Tooth Whitening: a Randomized Clinical Trial Completed NCT02741427 Phase 4
37 Comparison Between Vaginal and Sublingual Misoprostol 50 µg for Cervical Ripening Prior to Induction of Labor: Randomized Clinical Trial Completed NCT02732522 Phase 4 Sublingual misoprostol;Vaginal misoprostol
38 Managing Post Spinal Hypotension During Elective Cesarean Section: Epinephrine Versus Ephedrine, a Randomized Double-blinded Controlled Trial Completed NCT03704909 Phase 4 Adrenaline;Ephedrine
39 Comparing Opioid Prescription Patterns in Total Joint Arthroplasty Patients: A Randomized Controlled Trial Completed NCT03236155 Phase 4 opioid pain pills
40 The Population Pharmacokinetics of Imipenem in Patients With Ventilator-associated Pneumonia Completed NCT01489124 Phase 4 Imipenem;Imipenem;Imipenem
41 A Comparative Evaluation of Diclofenac Sodium Transdermal Patch, Oral Diclofenac Sodium With Intramuscular Injections of Diclofenac Sodium in Patients Suffering From Oral Pain: A Randomized Control Trial Completed NCT03221946 Phase 4 Diclofenac Sodium;Diclofenac sodium;Diclofenac
42 Acute Insulin Effects on Cardiac Function in Patients With Diabetes Mellitus Completed NCT02962921 Phase 4 Insulin LISPRO intravenous loading
43 Comparison of Three Different Anesthetic Approaches for Intravitreal Injections: A Prospective Randomized Trial Completed NCT02263690 Phase 4
44 Role of Empiric Anti-reflux Therapy in Pediatric Otitis Media With Effusion - a Pilot Study Completed NCT01082029 Phase 4 Lansoprazole;Placebo
45 Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution Alone and In Combination on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen. Completed NCT01007253 Phase 4 PL nasal spray;fluticasone furoate (FF);PL eye drops;olopatadine (OLO)
46 Comparison of Bilateral Internal Thoracic Artery Revascularization Using in Situ or Y Graft Configurations: a Prospective Randomized Clinical, Functional and Angiographic Evaluation Completed NCT01666366 Phase 4
47 Comparison of Autologous Serum Versus Preservative Free Artificial Tear in Patients With Dry Eye Due to Systemic Isotretinoin Therapy Completed NCT02752763 Phase 4 %40 diluted Autologous serum;Preservative free artificial tears(Tears naturale free, Refresh single dose eye drop)
48 A Novel Assay for the Determination of Urinary 2,8-Dihydroxyadenine and Other Key Urinary Purine Metabolites: Effect of Allopurinol and Febuxostat on Urinary 2,8-Dihydroxyadenine Excretion in APRT Deficient Patients Completed NCT02752633 Phase 4 Allopurinol;Febuxostat
49 Postoperative Antibiotic Requirements Following Immediate Breast Reconstruction Completed NCT01244698 Phase 4 Cefadroxil discontinued early;Cefadroxil until drain removal
50 Phase 4 Study of Prevention of Persistent Postsurgical Pain After Thoracotomy Using Ketamine Completed NCT01243801 Phase 4 Ketamine

Search NIH Clinical Center for Gastric Antral Vascular Ectasia

Cochrane evidence based reviews: gastric antral vascular ectasia

Genetic Tests for Gastric Antral Vascular Ectasia

Anatomical Context for Gastric Antral Vascular Ectasia

MalaCards organs/tissues related to Gastric Antral Vascular Ectasia:

41
Liver, Testes, Heart, Bone, Brain, Breast, T Cells

Publications for Gastric Antral Vascular Ectasia

Articles related to Gastric Antral Vascular Ectasia:

(show top 50) (show all 447)
# Title Authors PMID Year
1
Comparative Effectiveness and Safety of Radiofrequency Ablation Versus Argon Plasma Coagulation for Treatment of Gastric Antral Vascular Ectasia: A Systematic Review and Meta-Analysis. 38
29952856 2019
2
Response of authors to the comment on 'mucosal miR-3677 is over-expressed in cirrhotic patients with gastric antral vascular ectasia'. 38
31165646 2019
3
Killer-cell immunoglobulin-like receptor ligand mismatch cord blood transplantation in high-risk neuroblastoma. 38
30974480 2019
4
Gastric Antral Vascular Ectasia Causing Refractory Anemia in a Patient With Systemic Sclerosis. 38
31107696 2019
5
Comment on "Mucosal miR-3677 is over-expressed in cirrhotic patients with gastric antral vascular ectasia (GAVE)". 38
31095437 2019
6
Laparoscopic subtotal gastrectomy with Roux-en-Y reconstruction for long-term anticoagulation in gastric antral vascular ectasia syndrome. 38
31138599 2019
7
Severe gastrointestinal hemorrhage related to everolimus: a case report. 38
30955165 2019
8
'Watermelon stomach' as a presenting manifestation of systemic sclerosis. 38
31323093 2019
9
Radiofrequency ablation for patients with refractory symptomatic anaemia secondary to gastric antral vascular ectasia. 38
31080606 2019
10
Predictors of blood transfusion and in-hospital outcomes in patients with gastric antral vascular ectasia (GAVE): a nationwide population-based analysis. 38
30906750 2019
11
Intravenous Cyclophosphamide for Gastric Antral Vascular Ectasia Associated with Systemic Sclerosis Refractory to Endoscopic Treatment: A Case Report and Review of the Pertinent Literature. 38
30101944 2019
12
Features of multiple self-healing squamous epithelioma and Loeys-Dietz syndrome in a patient with a novel TGFBR1 variant. 38
30513140 2018
13
Mucosal miR-3677 is over-expressed in cirrhotic patients with gastric antral vascular ectasia (GAVE). 38
30621516 2018
14
Angiosarcoma with Synchronous Cutaneous and Small Bowel Involvement: A Report of a Rare Presentation. 38
30723649 2018
15
Diagnosis and Management of Gastric Antral Vascular Ectasia: Experience in a Large Single Cohort of Patients With Systemic Sclerosis. 38
30431488 2018
16
Nitrous oxide cryotherapy ablation for refractory gastric antral vascular ectasia. 38
30288277 2018
17
Gastric antral vascular ectasia in portal hypertensive children: Endoscopic band ligation versus argon plasma coagulation. 38
30119927 2018
18
Gastric Antral Vascular Ectasia Pathogenesis and the Link to the Metabolic Syndrome. 38
29961911 2018
19
New Indications for Endoscopic Radiofrequency Ablation. 38
29081376 2018
20
The Role of Therapeutic Endoscopy in Patients With Cirrhosis-Related Causes of Gastrointestinal Bleeding. 38
29886513 2018
21
[Diagnostic and therapeutic approach to Gastric antral vascular ectasia (GAVE): A case report and review of the literature]. 38
29663241 2018
22
An Analysis of the Clinical, Laboratory, and Histological Features of Striped, Punctate, and Nodular Gastric Antral Vascular Ectasia. 38
29450749 2018
23
Radiofrequency ablation (RFA) vs. argon plasma coagulation (APC) for the management of gastric antral vascular ectasia (GAVE) in patients with and without cirrhosis: results from a retrospective analysis of a large cohort of patients treated at a single center. 38
29497685 2018
24
Gastric Antral Vascular Ectasia: A Case Report and Literature Review. 38
29607305 2018
25
Gastric antral vascular ectasia presenting as a polypoid mass in a patient with cirrhosis. 38
28803743 2018
26
Gastric antral vascular ectasia should not be overlooked in erythropoietin resistance: a series of case reports. 38
31308827 2018
27
Case series on multimodal endoscopic therapy for gastric antral vascular ectasia, a tertiary center experience. 38
29375739 2018
28
HSCT-GAVE as a Manifestation of Chronic Graft versus Host Disease: A Case Report and Review of the Existing Literature. 38
29721346 2018
29
[Systemic sclerosis in 2017]. 38
29595279 2018
30
Insights into the management of gastric antral vascular ectasia (watermelon stomach). 38
29399041 2018
31
Gastric antral vascular ectasia in systemic sclerosis: Where do we stand? 38
28217887 2017
32
Upper gastrointestinal bleeding (watermelon stomach) in a patient with limited scleroderma (CREST syndrome). 38
27353193 2017
33
Gastric Antral Vascular Ectasia and Metabolic Syndrome: Is There a Case for an Association? 38
29073974 2017
34
Nitrous oxide CryoBalloon therapy of refractory gastric antral vascular ectasia. 38
28679138 2017
35
An update on biomarker discovery and use in systemic sclerosis. 38
28730919 2017
36
Randomized controlled trial of scleroligation versus band ligation alone for eradication of gastroesophageal varices. 38
28082116 2017
37
Orthotopic liver transplantation changes the course of gastric antral vascular ectasia: a case series from a transplant center. 38
28520574 2017
38
Etiological and Endoscopic Profile of Middle Aged and Elderly Patients with Upper Gastrointestinal Bleeding in a Tertiary Care Hospital in North India: A Retrospective Analysis. 38
28983161 2017
39
Endoscopic Treatment for Gastric Antral Vascular Ectasia: Current Options. 38
29255747 2017
40
Endoscopic resolution and recurrence of gastric antral vascular ectasia after serial treatment with argon plasma coagulation. 38
28690769 2017
41
["Watermelon stomach" can be the cause of severe gastrointestinal bleeding]. 38
28621190 2017
42
[Oesophageal vascular ectasia in a patient with anaemia]. 38
28553915 2017
43
Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening. 38
28089973 2017
44
Antral mucosal perfusion is not increased in GAVE. 38
28299959 2017
45
Watermelon stomach and colon in a patient with diffuse cutaneous systemic sclerosis. 38
27414211 2017
46
Radiofrequency ablation for gastric antral vascular ectasia and radiation proctitis. 38
28367587 2017
47
Gastric antral vascular ectasia and solitary rectal ulcer syndrome - two rare diagnoses as the cause of anemia in a single patient: case report. 38
28726433 2017
48
Vascular-targeted photodynamic therapy of gastric antral vascular ectasia (GAVE). 38
27871022 2017
49
Radiofrequency Ablation for Treatment of Refractory Gastric Antral Vascular Ectasia: A Systematic Review of the Literature. 38
28835751 2017
50
A Case of Gastric Antral Vascular Ectasia Which Was Aggravated by Acid Reducer. 38
28611555 2017

Variations for Gastric Antral Vascular Ectasia

Expression for Gastric Antral Vascular Ectasia

Search GEO for disease gene expression data for Gastric Antral Vascular Ectasia.

Pathways for Gastric Antral Vascular Ectasia

GO Terms for Gastric Antral Vascular Ectasia

Biological processes related to Gastric Antral Vascular Ectasia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 potassium ion import across plasma membrane GO:1990573 9.37 ATP4A ATP12A
2 ATP hydrolysis coupled proton transport GO:0015991 9.32 ATP4A ATP12A
3 cellular sodium ion homeostasis GO:0006883 9.26 ATP4A ATP12A
4 establishment or maintenance of transmembrane electrochemical gradient GO:0010248 9.16 ATP4A ATP12A
5 sodium ion export across plasma membrane GO:0036376 8.96 ATP4A ATP12A
6 cellular potassium ion homeostasis GO:0030007 8.62 ATP4A ATP12A

Molecular functions related to Gastric Antral Vascular Ectasia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 sodium:potassium-exchanging ATPase activity GO:0005391 8.96 ATP4A ATP12A
2 potassium:proton exchanging ATPase activity GO:0008900 8.62 ATP4A ATP12A

Sources for Gastric Antral Vascular Ectasia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....